Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM
Clinical trial NCT06455254 · UNKNOWN
Trial details
- NCT number
- NCT06455254
- Sponsor
- Jin-hong Chen
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-11
- Primary completion
- 2025-12-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.